Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 398 studies with search of: | "Ritonavir" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
|
||||
2 | Recruiting |
GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir
|
||||
3 | Recruiting |
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
|
||||
4 | Active, not recruiting |
Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
|
||||
5 | Recruiting |
Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1
|
||||
6 | Completed |
A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
|
||||
7 | Terminated |
A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults
|
||||
8 | Completed |
Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
|
||||
9 | Completed |
Bioequivalence Study of Generic GPO Ritonavir Versus Norvir®
|
||||
10 | Active, not recruiting |
Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
|
||||
11 | Completed |
Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens
|
||||
12 | Completed |
Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients
|
||||
13 | Recruiting |
GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir
|
||||
14 | Completed |
Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
|
||||
15 | Completed |
Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
|
||||
16 | Not yet recruiting |
Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.
|
||||
17 | Completed |
Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
|
||||
18 | Completed |
Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor
|
||||
19 | Completed |
ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
|
||||
20 | Terminated |
Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |